News
ONPH
0.0050
0.00%
0.0000
Weekly Report: what happened at ONPH last week (1208-1212)?
Weekly Report · 5d ago
Weekly Report: what happened at ONPH last week (1201-1205)?
Weekly Report · 12/08 09:44
Weekly Report: what happened at ONPH last week (1124-1128)?
Weekly Report · 12/01 09:42
Weekly Report: what happened at ONPH last week (1117-1121)?
Weekly Report · 11/24 09:44
Weekly Report: what happened at ONPH last week (1110-1114)?
Weekly Report · 11/17 09:45
Weekly Report: what happened at ONPH last week (1103-1107)?
Weekly Report · 11/10 09:43
Weekly Report: what happened at ONPH last week (1027-1031)?
Weekly Report · 11/03 09:42
Weekly Report: what happened at ONPH last week (1020-1024)?
Weekly Report · 10/27 09:45
Weekly Report: what happened at ONPH last week (1013-1017)?
Weekly Report · 10/20 09:43
Weekly Report: what happened at ONPH last week (1006-1010)?
Weekly Report · 10/13 09:44
Weekly Report: what happened at ONPH last week (0929-1003)?
Weekly Report · 10/06 09:43
Weekly Report: what happened at ONPH last week (0922-0926)?
Weekly Report · 09/29 09:43
Weekly Report: what happened at ONPH last week (0915-0919)?
Weekly Report · 09/22 09:43
Weekly Report: what happened at ONPH last week (0908-0912)?
Weekly Report · 09/15 11:48
Weekly Report: what happened at ONPH last week (0901-0905)?
Weekly Report · 09/08 11:50
Weekly Report: what happened at ONPH last week (0825-0829)?
Weekly Report · 09/01 11:44
Weekly Report: what happened at ONPH last week (0818-0822)?
Weekly Report · 08/25 11:58
Weekly Report: what happened at ONPH last week (0811-0815)?
Weekly Report · 08/18 11:48
Weekly Report: what happened at ONPH last week (0804-0808)?
Weekly Report · 08/11 11:57
Weekly Report: what happened at ONPH last week (0728-0801)?
Weekly Report · 08/04 12:00
More
Webull provides a variety of real-time ONPH stock news. You can receive the latest news about Oncology Pharma through multiple platforms. This information may help you make smarter investment decisions.
About ONPH
Oncology Pharma, Inc. is an oncology company. The Company is focused on licensing, developing, manufacturing and commercializing therapeutics. The Company’s research, development, and commercialization of therapeutic drugs and medical devices designed for the treatment of many types of cancers. The Company offers a portfolio, such as Nanosmart Pharmaceuticals Inc. (Nanosmart Pharmaceuticals). The Company’s NanoSmart platform technology is a human-derived, antinuclear antibody (ANA) that targets areas of necrosis present in solid tumors. Its anti-cancer drugs in combination with medications, for treating a variety of cancers, such as breast, ovarian, lung, bladder, Kaposi's sarcoma, lymphoma and acute lymphocytic leukemia is doxorubicin. Its portfolio also includes Connect2Med, Sybleu, Inc. and Regen.